Sumitomo Mitsui Trust Group’s Corcept Therapeutics CORT Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$321K	Buy	+3,688	New	+$223K	﹤0.01%	1029
2025 Q4	–	Sell	-3,389	Closed	-$282K	–	1060
2025 Q3	$282K	Buy	3,389 +260	+8%	+$18.8K	﹤0.01%	1018
2025 Q2	$230K	Buy	3,129 +230	+8%	+$16.7K	﹤0.01%	1011
2025 Q1	$331K	Buy	+2,899	New	+$176K	﹤0.01%	972
2022 Q3	–	Sell	-12,007	Closed	-$286K	–	1209
2022 Q2	$286K	Buy	+12,007	New	+$262K	﹤0.01%	1181
2020 Q3	–	Sell	-20,649	Closed	-$347K	–	1104
2020 Q2	$347K	Buy	+20,649	New	+$290K	﹤0.01%	1049

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sumitomo Mitsui Trust Group's CORT Position: Q2 2026 in Review

Sumitomo Mitsui Trust Group opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 3,688 shares worth $321K. The stake represents ﹤0.01% of the portfolio and ranks #1029 among its holdings. This is a return to the name: Sumitomo Mitsui Trust Group previously reported a position in CORT as recently as Q3 2025.

Sumitomo Mitsui Trust Group first reported a position in CORT in Q2 2020 and has held it in 6 quarters since. The position peaked at $347K in Q2 2020. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

Sumitomo Mitsui Trust Group held 3,688 shares of Corcept Therapeutics worth $321K as of Q2 2026.
Corcept Therapeutics was a new Sumitomo Mitsui Trust Group position in Q2 2026.
Corcept Therapeutics made up ﹤0.01% of Sumitomo Mitsui Trust Group's portfolio in Q2 2026, its #1029 holding.
Sumitomo Mitsui Trust Group first reported a position in Corcept Therapeutics in Q2 2020 and has held it in 6 quarters since.
Sumitomo Mitsui Trust Group's Corcept Therapeutics position peaked at $347K in Q2 2020.
422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2026, filed 30 Jul 2026.